vs
REPLIGEN CORP（RGEN）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Rocket Lab Corp的1.1倍（$197.9M vs $179.7M），REPLIGEN CORP净利率更高（6.7% vs -29.5%，领先36.2%），Rocket Lab Corp同比增速更快（35.7% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $-114.2M），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 14.4%）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
RGEN vs RKLB — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$179.7M
营收增速更快
RKLB
高出22.1%
13.6%
净利率更高
RGEN
高出36.2%
-29.5%
自由现金流更多
RGEN
多$131.7M
$-114.2M
两年增速更快
RKLB
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $197.9M | $179.7M |
| 净利润 | $13.3M | $-52.9M |
| 毛利率 | 52.5% | 38.0% |
| 营业利润率 | 9.0% | -28.4% |
| 净利率 | 6.7% | -29.5% |
| 营收同比 | 13.6% | 35.7% |
| 净利润同比 | 143.9% | -1.1% |
| 每股收益（稀释后） | $0.24 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RGENRKLB
| Q4 25 | $197.9M | $179.7M | ||
| Q3 25 | $188.8M | $155.1M | ||
| Q2 25 | $182.4M | $144.5M | ||
| Q1 25 | $169.2M | $122.6M | ||
| Q4 24 | $174.1M | $132.4M | ||
| Q3 24 | $154.9M | $104.8M | ||
| Q2 24 | $154.1M | $106.3M | ||
| Q1 24 | $151.3M | $92.8M |
净利润RGENRKLB
| Q4 25 | $13.3M | $-52.9M | ||
| Q3 25 | $14.9M | $-18.3M | ||
| Q2 25 | $14.9M | $-66.4M | ||
| Q1 25 | $5.8M | $-60.6M | ||
| Q4 24 | $-30.3M | $-52.3M | ||
| Q3 24 | $-654.0K | $-51.9M | ||
| Q2 24 | $3.3M | $-41.6M | ||
| Q1 24 | $2.1M | $-44.3M |
毛利率RGENRKLB
| Q4 25 | 52.5% | 38.0% | ||
| Q3 25 | 53.2% | 37.0% | ||
| Q2 25 | 50.0% | 32.1% | ||
| Q1 25 | 53.6% | 28.8% | ||
| Q4 24 | 26.1% | 27.8% | ||
| Q3 24 | 50.0% | 26.7% | ||
| Q2 24 | 49.8% | 25.6% | ||
| Q1 24 | 49.5% | 26.1% |
营业利润率RGENRKLB
| Q4 25 | 9.0% | -28.4% | ||
| Q3 25 | 8.9% | -38.0% | ||
| Q2 25 | 7.6% | -41.3% | ||
| Q1 25 | 3.9% | -48.3% | ||
| Q4 24 | -17.7% | -38.9% | ||
| Q3 24 | -5.1% | -49.5% | ||
| Q2 24 | 1.0% | -40.7% | ||
| Q1 24 | 1.3% | -46.4% |
净利率RGENRKLB
| Q4 25 | 6.7% | -29.5% | ||
| Q3 25 | 7.9% | -11.8% | ||
| Q2 25 | 8.2% | -46.0% | ||
| Q1 25 | 3.4% | -49.5% | ||
| Q4 24 | -17.4% | -39.5% | ||
| Q3 24 | -0.4% | -49.6% | ||
| Q2 24 | 2.2% | -39.2% | ||
| Q1 24 | 1.4% | -47.7% |
每股收益（稀释后）RGENRKLB
| Q4 25 | $0.24 | $-0.09 | ||
| Q3 25 | $0.26 | $-0.03 | ||
| Q2 25 | $0.26 | $-0.13 | ||
| Q1 25 | $0.10 | $-0.12 | ||
| Q4 24 | $-0.55 | $-0.11 | ||
| Q3 24 | $-0.01 | $-0.10 | ||
| Q2 24 | $0.06 | $-0.08 | ||
| Q1 24 | $0.04 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $767.6M | $1.0B |
| 总债务越低越好 | $542.2M | $152.4M |
| 股东权益账面价值 | $2.1B | $1.7B |
| 总资产 | $2.9B | $2.3B |
| 负债/权益比越低杠杆越低 | 0.26× | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资RGENRKLB
| Q4 25 | $767.6M | $1.0B | ||
| Q3 25 | $748.7M | $976.7M | ||
| Q2 25 | $708.9M | $688.1M | ||
| Q1 25 | $697.2M | $428.4M | ||
| Q4 24 | $757.4M | $419.0M | ||
| Q3 24 | $784.0M | $442.4M | ||
| Q2 24 | $809.1M | $496.8M | ||
| Q1 24 | $780.6M | $492.5M |
总债务RGENRKLB
| Q4 25 | $542.2M | $152.4M | ||
| Q3 25 | $537.9M | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | $525.6M | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
股东权益RGENRKLB
| Q4 25 | $2.1B | $1.7B | ||
| Q3 25 | $2.1B | $1.3B | ||
| Q2 25 | $2.1B | $688.5M | ||
| Q1 25 | $2.0B | $431.3M | ||
| Q4 24 | $2.0B | $382.5M | ||
| Q3 24 | $2.0B | $419.8M | ||
| Q2 24 | $2.0B | $455.2M | ||
| Q1 24 | $2.0B | $478.9M |
总资产RGENRKLB
| Q4 25 | $2.9B | $2.3B | ||
| Q3 25 | $2.9B | $2.2B | ||
| Q2 25 | $2.9B | $1.6B | ||
| Q1 25 | $2.9B | $1.3B | ||
| Q4 24 | $2.8B | $1.2B | ||
| Q3 24 | $2.8B | $1.2B | ||
| Q2 24 | $2.9B | $1.2B | ||
| Q1 24 | $2.8B | $1.2B |
负债/权益比RGENRKLB
| Q4 25 | 0.26× | 0.09× | ||
| Q3 25 | 0.26× | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | 0.27× | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.7M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | $17.6M | $-114.2M |
| 自由现金流率自由现金流/营收 | 8.9% | -63.6% |
| 资本支出强度资本支出/营收 | 4.1% | 27.6% |
| 现金转化率经营现金流/净利润 | 1.93× | — |
| 过去12个月自由现金流最近4个季度 | $93.9M | $-321.8M |
8季度趋势，按日历期对齐
经营现金流RGENRKLB
| Q4 25 | $25.7M | $-64.5M | ||
| Q3 25 | $48.1M | $-23.5M | ||
| Q2 25 | $28.6M | $-23.2M | ||
| Q1 25 | $15.0M | $-54.2M | ||
| Q4 24 | $39.2M | $-2.4M | ||
| Q3 24 | $49.3M | $-30.9M | ||
| Q2 24 | $42.2M | $-13.0M | ||
| Q1 24 | $44.7M | $-2.6M |
自由现金流RGENRKLB
| Q4 25 | $17.6M | $-114.2M | ||
| Q3 25 | $43.4M | $-69.4M | ||
| Q2 25 | $21.5M | $-55.3M | ||
| Q1 25 | $11.4M | $-82.9M | ||
| Q4 24 | $33.6M | $-23.9M | ||
| Q3 24 | $42.3M | $-41.9M | ||
| Q2 24 | $37.4M | $-28.3M | ||
| Q1 24 | $36.4M | $-21.8M |
自由现金流率RGENRKLB
| Q4 25 | 8.9% | -63.6% | ||
| Q3 25 | 23.0% | -44.8% | ||
| Q2 25 | 11.8% | -38.3% | ||
| Q1 25 | 6.8% | -67.6% | ||
| Q4 24 | 19.3% | -18.1% | ||
| Q3 24 | 27.3% | -40.0% | ||
| Q2 24 | 24.3% | -26.7% | ||
| Q1 24 | 24.0% | -23.5% |
资本支出强度RGENRKLB
| Q4 25 | 4.1% | 27.6% | ||
| Q3 25 | 2.5% | 29.6% | ||
| Q2 25 | 3.9% | 22.2% | ||
| Q1 25 | 2.1% | 23.4% | ||
| Q4 24 | 3.2% | 16.3% | ||
| Q3 24 | 4.5% | 10.5% | ||
| Q2 24 | 3.1% | 14.4% | ||
| Q1 24 | 5.5% | 20.7% |
现金转化率RGENRKLB
| Q4 25 | 1.93× | — | ||
| Q3 25 | 3.23× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.57× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 12.70× | — | ||
| Q1 24 | 21.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RGEN
暂无分部数据
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
